These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 2596063
1. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer]. Zhalgasbaeva GT, Baisheva SA, Ozerova IV, Friazinova TS, Kuralasov AK. Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063 [Abstract] [Full Text] [Related]
2. [Disorders of the immune system in benign lesions and cancer of the breast]. Derevnina NA, Polevaia EB, Veskova TK, Trubcheninova LP, Bogatyrev VN. Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960 [Abstract] [Full Text] [Related]
3. [Dynamic sampling analysis of the immune status of breast cancer patients]. Eremina OF, Kunitsyna TA, Sharonina AI. Vopr Onkol; 1985; 31(6):33-7. PubMed ID: 3875181 [Abstract] [Full Text] [Related]
4. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract]. Kupin VI, Polevaia EB. Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720 [Abstract] [Full Text] [Related]
5. [Functional activity of the regional lymph nodes in breast cancer patients]. Loboda VI, Grinevich IuA. Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329 [Abstract] [Full Text] [Related]
6. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer]. Fedin IuV, Ermilova VD. Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934 [Abstract] [Full Text] [Related]
7. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer. Tsang PH, Holland JF, Bekesi JG. J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442 [Abstract] [Full Text] [Related]
10. T and B lymphocytes in cancer patients. Sengupta U, Dutta TK, Gupta BD, Aikat BK. Indian J Cancer; 1978 Jun; 15(2):6-9. PubMed ID: 312245 [No Abstract] [Full Text] [Related]
11. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer]. Grinevich IuA, Drannik GN, Nikol'skiĭ IS, Kalinina NA, Litvishchenko EI. Vopr Onkol; 1984 Jun; 30(12):23-7. PubMed ID: 6240157 [Abstract] [Full Text] [Related]
12. [Quantitative morphological characteristics of the changes in the effector component of the immune system in dyshormonal hyperplasias and breast cancer]. Abrakova EL. Vopr Onkol; 1982 Jun; 28(10):81-5. PubMed ID: 7147824 [Abstract] [Full Text] [Related]
13. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer. Olusi SO, Oluwole SF, Odesanmi WO. Afr J Med Med Sci; 1984 Jun; 13(3-4):103-9. PubMed ID: 6099969 [Abstract] [Full Text] [Related]
14. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration]. Mkrtchian LN, Galstian AM, Ovanesbekova TG, Ter-Pogosian ZR, Kuznetsov VP. Vopr Onkol; 1986 Jun; 32(10):25-31. PubMed ID: 3490716 [Abstract] [Full Text] [Related]
15. [Comparative characteristics of the immunologic indicators in patients with prostatic adenoma and cancer]. Savinov VA, Khalezov SP, Sviridova AM. Urol Nefrol (Mosk); 1983 Jun; (2):17-20. PubMed ID: 6190286 [No Abstract] [Full Text] [Related]
16. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies. Nowak JS, Lanzrein C. Neoplasma; 1984 Jun; 31(3):281-9. PubMed ID: 6610835 [Abstract] [Full Text] [Related]
17. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase]. Strache RR, Büttner HH, Kunze M, Röpcke G. Zentralbl Gynakol; 1989 Jun; 111(12):816-23. PubMed ID: 2788342 [Abstract] [Full Text] [Related]